1,444
Views
2
CrossRef citations to date
0
Altmetric
Research Papers

Facing facial weakness: psychosocial outcomes of facial weakness and reduced facial function in facioscapulohumeral muscular dystrophy

, ORCID Icon, , , , , , , , & show all
Pages 2507-2516 | Received 17 Dec 2021, Accepted 17 Jun 2022, Published online: 10 Jul 2022

References

  • Hamel J, Tawil R. Facioscapulohumeral muscular dystrophy: update on pathogenesis and future treatments. Neurotherapeutics. 2018;15(4):863–871.
  • Statland JM, Tawil R. Facioscapulohumeral muscular dystrophy. Continuum. 2016;22:1916–1931.
  • Tawil R, van der Maarel S, Padberg GW, et al. 171st ENMC International Workshop: standards of care and management of facioscapulohumeral muscular dystrophy. Neuromuscul Disord. 2010;20(7):471–475.
  • Tawil R, Kissel JT, Heatwole C, et al. Evidence-based guideline summary: evaluation, diagnosis, and management of facioscapulohumeral muscular dystrophy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine. Neurology. 2015;85(4):357–364.
  • Banerji CRS, Cammish P, Evangelista T, et al. Facioscapulohumeral muscular dystrophy 1 patients participating in the UK FSHD registry can be subdivided into 4 patterns of self-reported symptoms. Neuromuscul Disord. 2020;30(4):315–328.
  • Deenen JC, Arnts H, van der Maarel SM, et al. Population-based incidence and prevalence of facioscapulohumeral dystrophy. Neurology. 2014;83(12):1056–1059.
  • Smith AE, McMullen K, Jensen MP, et al. Symptom burden in persons with myotonic and facioscapulohumeral muscular dystrophy. Am J Phys Med Rehabil. 2014;93(5):387–395.
  • Bakker M, Schipper K, Geurts AC, et al. It's not just physical: a qualitative study regarding the illness experiences of people with facioscapulohumeral muscular dystrophy. Disabil Rehabil. 2017;39(10):978–986.
  • Schipper K, Bakker M, Abma T. Fatigue in facioscapulohumeral muscular dystrophy: a qualitative study of people's experiences. Disabil Rehabil. 2017;39(18):1840–1846.
  • Hamel J, Johnson N, Tawil R, et al. Patient-reported symptoms in facioscapulohumeral muscular dystrophy (PRISM-FSHD). Neurology. 2019;93(12):e1180–e1192.
  • Johnson NE, Quinn C, Eastwood E, et al. Patient-identified disease burden in facioscapulohumeral muscular dystrophy. Muscle Nerve. 2012;46(6):951–953.
  • Graham CD, Rose MR, Grunfeld EA, et al. A systematic review of quality of life in adults with muscle disease. J Neurol. 2011;258(9):1581–1592.
  • Padua L, Aprile I, Frusciante R, et al. Quality of life and pain in patients with facioscapulohumeral muscular dystrophy. Muscle Nerve. 2009;40(2):200–205.
  • Loonen TGJ, Horlings CGC, Vincenten SCC, et al. Characterizing the face in facioscapulohumeral muscular dystrophy. J Neurol. 2021;268(4):1342–1350.
  • Bogart KR, Tickle-Degnen L, Joffe MS. Social interaction experiences of adults with Moebius syndrome: a focus group. J Health Psychol. 2012;17(8):1212–1222.
  • Bradbury E. Meeting the psychological needs of patients with facial disfigurement. Br J Oral Maxillofac Surg. 2012;50(3):193–196.
  • Bylund N, Hultcrantz M, Jonsson L, et al. Quality of life in Bell's palsy: correlation with Sunnybrook and House–Brackmann over time. Laryngoscope. 2020;131(2):E612–E618.
  • Hemmesch AR. The detrimental effects of atypical nonverbal behavior on older adults' first impressions of individuals with Parkinson's disease. Psychol Aging. 2014;29(3):521–527.
  • Hotton M, Huggons E, Hamlet C, et al. The psychosocial impact of facial palsy: a systematic review. Br J Health Psychol. 2020;25(3):695–727.
  • Ishii LE, Nellis JC, Boahene KD, et al. The importance and psychology of facial expression. Otolaryngol Clin North Am. 2018;51(6):1011–1017.
  • Kim JH, Fisher LM, Reder L, et al. Speech and communicative participation in patients with facial paralysis. JAMA Otolaryngol Head Neck Surg. 2018;144(8):686–693.
  • Mul K, Berggren KN, Sills MY, et al. Effects of weakness of orofacial muscles on swallowing and communication in FSHD. Neurology. 2019;92(9):e957–e963.
  • Wootton A, Starkey NJ, Barber CC. Unmoving and unmoved: experiences and consequences of impaired non-verbal expressivity in Parkinson's patients and their spouses. Disabil Rehabil. 2019;41(21):2516–2527.
  • VanSwearingen JM, Cohn JF, Bajaj-Luthra A. Specific impairment of smiling increases the severity of depressive symptoms in patients with facial neuromuscular disorders. Aesthetic Plast Surg. 1999;23(6):416–423.
  • Nederland F. De Nachtmerrie van Iedere Cabaretier. YouTube; 2017. Available from: https://www.youtube.com/watch?v=UqOim1pbPT4
  • Journalists V. I cannot smile. Linda (Dutch glossy magazine); 2018.
  • Sezer S, Cup EHC, Roets-Merken LM, et al. Experiences of patients with facioscapulohumeral dystrophy with facial weakness: a qualitative study. Disabil Rehabil. 2021;16:1–8.
  • Mul K, Voermans NC, Lemmers R, et al. Phenotype–genotype relations in facioscapulohumeral muscular dystrophy type 1. Clin Genet. 2018;94(6):521–527.
  • FSHD databank en registratie. Available from: www.fshdregistratie.nl
  • Lamperti C, Fabbri G, Vercelli L, et al. A standardized clinical evaluation of patients affected by facioscapulohumeral muscular dystrophy: the FSHD clinical score. Muscle Nerve. 2010;42(2):213–217.
  • Mul K, Hamadeh T, Horlings CGC, et al. The facioscapulohumeral muscular dystrophy Rasch-built overall disability scale (FSHD-RODS). Eur J Neurol. 2021;28(7):2339–2348.
  • Kahn JB, Gliklich RE, Boyev KP, et al. Validation of a patient-graded instrument for facial nerve paralysis: the FaCE scale. Laryngoscope. 2001;111(3):387–398.
  • VanSwearingen JM, Brach JS. The Facial Disability Index: reliability and validity of a disability assessment instrument for disorders of the facial neuromuscular system. Phys Ther. 1996;76(12):1288–1298.
  • Spinhoven P, Ormel J, Sloekers PP, et al. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med. 1997;27(2):363–370.
  • Aaronson NK, Muller M, Cohen PD, et al. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol. 1998;51(11):1055–1068.
  • Levinson CA, Rodebaugh TL. Validation of the Social Appearance Anxiety Scale: factor, convergent, and divergent validity. Assessment. 2011;18(3):350–356.
  • Beurs dE, Tielen D, Wollmann L. The Dutch Social Interaction Anxiety Scale and the Social Phobia Scale: reliability, validity, and clinical utility. Psychiatry J. 2014;2014:360193.
  • Vercoulen JH, Swanink CM, Fennis JF, et al. Dimensional assessment of chronic fatigue syndrome. J Psychosom Res. 1994;38(5):383–392.
  • Crawford JR, Henry JD, Crombie C, et al. Normative data for the HADS from a large non-clinical sample. Br J Clin Psychol. 2001;40(4):429–434.
  • Pouwels S, Beurskens CH, Kleiss IJ, et al. Assessing psychological distress in patients with facial paralysis using the Hospital Anxiety and Depression Scale. J Plast Reconstr Aesthet Surg. 2016;69(8):1066–1071.
  • Zee K, Sanderman R. Het meten van de algemene gezondheidstoestand met de RAND-36. Noordelijk Centrum voor Gezondheidsvraagstukken, reeks meetinstrumenten; 1993. p. 1–28.
  • Wohlgemuth M, Lemmers RJ, Jonker M, et al. A family-based study into penetrance in facioscapulohumeral muscular dystrophy type 1. Neurology. 2018;91(5):e444–e454.
  • Volk GF, Granitzka T, Kreysa H, et al. Nonmotor disabilities in patients with facial palsy measured by patient-reported outcome measures. Laryngoscope. 2016;126(7):1516–1523.
  • Kleiss IJ, Hohman MH, Susarla SM, et al. Health-related quality of life in 794 patients with a peripheral facial palsy using the FaCE Scale: a retrospective cohort study. Clin Otolaryngol. 2015;40(6):651–656.
  • Peric M, Peric S, Stevanovic J, et al. Quality of life in adult patients with limb-girdle muscular dystrophies. Acta Neurol Belg. 2018;118(2):243–250.
  • Del Rosso A, Mikhaylova S, Baccini M, et al. In systemic sclerosis, anxiety and depression assessed by hospital anxiety depression scale are independently associated with disability and psychological factors. Biomed Res Int. 2013;2013:1–8.
  • Mills SD, Kwakkenbos L, Carrier ME, et al. Validation of the Social Appearance Anxiety Scale in patients with systemic sclerosis: a scleroderma patient-centered intervention network cohort study. Arthritis Care Res. 2018;70(10):1557–1562.
  • Bogart KR, Tickle-Degnen L, Ambady N. Compensatory expressive behavior for facial paralysis: adaptation to congenital or acquired disability. Rehabil Psychol. 2012;57(1):43–51.
  • Dumer AI, Oster H, McCabe D, et al. Effects of the Lee Silverman Voice Treatment (LSVT(R) LOUD) on hypomimia in Parkinson's disease. J Int Neuropsychol Soc. 2014;20(3):302–312.
  • Bianchi B, Ferri A, Poddi V, et al. Facial animation with gracilis muscle transplant reinnervated via cross-face graft: does it change patients' quality of life? J Craniomaxillofac Surg. 2016;44(8):934–939.
  • Bradbury ET, Simons W, Sanders R. Psychological and social factors in reconstructive surgery for hemi-facial palsy. J Plast Reconstr Aesthet Surg. 2006;59(3):272–278.
  • Stichting Eigen Gezicht. Web page of a Dutch foundation, set up for people with an altered appearance. Includes an education program for elementary schools; 2020. Available from: https://eigengezicht.nl/